NFE2L1 and central nervous system cancer: Histological analysis through hematoxylin and eosin (HE) staining, accompanied by Ki67 proliferation assays, revealed that tumor growth and cellular proliferation were markedly inhibited in C57BL/6 mice with NFE2L1 deficiency following the implantation of GL261 glioma cells (Figure 4F).